events contact us
Search the complete PARC site
 
FAST Cytometer for Rare Cell Detection

The Fiber Array Scanning Technology (FAST) cytometer, developed as part of the Scripps-PARC Institute for Advanced Biomedical Sciences, uses lasers, opto-mechanical engineering, and imaging to detect rare cells almost 1000 times faster than digital microscopy, the current gold standard for sensitivity.

The term rare cells refers to uniquely identifiable cells that occur in a sample in extremely low concentrations – on the order of one in millions – and are associated with a number of conditions including cancer.


Scientists prepare a sample for scanning on the FAST Cytometer
larger image

A blood test for screening and monitoring cancer has been a long-term goal of biomedical science. Occult tumor cells (OTCs) have been found in peripheral blood, but their concentration is very low – one in millions. Detection of tumor cells in peripheral blood using immunocytochemistry and optical scanning is a promising method for screening and monitoring cancer. However, digital microscopy, the current gold standard for sensitivity, is far too slow for practical application in diagnostics and the low specificity requires substantial subsequent examination by a trained pathologist. To scan 50 million blood cells would take 32 hours, and thousands of objects would need to be reexamined by an expert.

PARC Approach

PARC's FAST cytometer is a pre-scan technology that can very rapidly find a small number of candidate objects, which are then examined with digital microscopy to determine if they are genuine tumor cells. The entire process is 1000-times faster than digital microscopy alone and has a similar sensitivity and specificity.

Architecture of PARC's FAST Cytometer
larger image

Testing begins with conventional staining of OTCs with fluorescent probes. The probes are attached to the OTC through an antibody reaction specific to the OTC. The peripheral blood sample is then rapidly scanned for the presence of these probes using a directed laser.

The key innovation in this work is the asymmetrically shaped fiber-optic bundle that collects the fluorescence. The collection end of the bundle is wide and thin. A laser is rapidly scanned across a sample that is positioned directly underneath this large (50mm) aperture. The collected fluorescence is transmitted to a collimating lens system through a small circular aperture at the other end of the bundle.


Sample image generated from FAST Cytometer; the system has detected 288 potential rare cells among over 50 million scanned
larger image

The collimation is appropriate for conventional optical filtering with subsequent detection in a photomultiplier. The optical filter system detects two emission wavelengths simultaneously to reduce noise from the staining process. A stage slowly moves the sample across the scanning field. The fluorescent object location can be computed from the position of the stage and laser beam at the time of detection.

BUSINESS CONTACT
Richard Bruce
Manager, Biomedical Systems
650-812-4447
NEWS

Scanning For Cancer, Forbes

Center Uses Laser Method to See Cancer, New York Times

Xerox in Pact To Develop Cancer Screening Tools, Wall Street Journal

Cancer Detection Made Faster, PhysicsWeb

Palo Alto Research Center and The Scripps Research Institute Partner To Accelerate Discovery Processes in the Life Sciences

PUBLICATIONS

High speed detection of circulating tumor cells, Biosensors & Bioelectronics

A rare cell detector for cancer [.pdf], Proceedings of the National Academy of Sciences

   

  (Logo/Homepage) PARC - Palo Alto Research Center

Copyright © 2002-2007 Palo Alto Research Center Incorporated. All Rights Reserved.
PARC, the PARC Logo, AspectJ, DataGlyph, Obje, Silx, StressedMetal, and ClawConnect
are trademarks or registered trademarks of Palo Alto Research Center Incorporated.